For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue from government contract | 0 | 852,282 | 1,636,863 | 432,207.5 |
| Research and development | 5,043,504 | 4,728,998 | 5,354,588 | 6,016,925 |
| General and administrative | 1,329,711 | 1,542,190 | 1,687,445 | 1,529,024 |
| Total operating expenses | 6,373,215 | 6,271,188 | 7,042,033 | 7,545,949 |
| Loss from operations | -6,373,215 | -5,418,906 | -5,405,170 | -7,113,741.5 |
| Interest income | 54,301 | 49,123 | 47,519 | 57,348.5 |
| Interest expense | 0 | 0 | - | 0 |
| Total other income (expense) | 54,301 | 49,123 | - | 57,348.5 |
| Net loss | -6,318,914 | -5,369,783 | -5,357,651 | -7,056,393 |
| Net loss per common share (in dollars per share) | -0.31 | -0.35 | -0.45 | -0.96 |
| Weighted average shares outstanding (in shares) | 20,287,203 | 15,359,220 | 11,954,797 | -1,878,818.5 |
GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc. (GOVX)